Chinese Startup OxiLight has made a device that can detect problematic wounds in diabetic foot ulcers and peripheral vascular diseases while at the same time reporting and documenting the data found. It uses multispectral imaging and AI that is remote and noninvasive. It is very easy to use and can be had at a very low cost.
Problems OxiLight can Solve
Diabetic foot ulcers can lead to amputations or even death. There are over 130 million diabetics in China. There are 2 million amputations a year and 69% of those amputees will die within 5 years. However, if they were diagnosed earlier, than up to 85% of the amputations could have been prevented. The average cost of treatment costs $4,000 and requires dye injections and a specialized lab. Furthermore, it will take a few days just to get the results.
Benefits of OxiLight
OxiLight is fast, easy to use, and can save time. It can have the result in seconds and that result can be analyzed by doctors. OxiLight’s imaging technology can separate viable and nonviable tissues in complex and compromised woods. This is a great IoT device for healthcare practitioners looking to save time. Upgrading to a diagnostics service that does not require a specialized vascular lab is the future of diagnostics in healthcare.
How it Works
The device extracts chromophores that have physiological relevance. It also takes multispectral wound images and gathers data related to wood type, location, size, tissue type, and exudate. The data is stored in a data warehouse (wound database). Then AI is used to build predictive and diagnostic models. No other device does this. Therefore, their predictive module will be the first of its kind. Those that could benefit Oxlight the most would be hospitals, clinics, nursing homes, and patients can all benefit from this product. It is remote and noninvasive. Hospitals need to think about licensing this technology for their own internal research and development team.